Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.760E-07 | 7.665E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0050896; response to stimulus | GO:0046686; response to cadmium ion | 5.384E-07 | 1.172E-03 | CYP1A2, KIT, MAPK1, NPC1 |
BP | GO:0032501; multicellular organismal process | GO:0006940; regulation of smooth muscle contraction | 9.854E-07 | 1.533E-03 | ADRA2A, ADRA2C, KIT, NMUR2 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.934E-06 | 2.340E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 2.571E-06 | 2.947E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0009987; cellular process | GO:0071310; cellular response to organic substance | 5.654E-06 | 4.767E-03 | ADRA2A, CYP1A1, CYP1B1, KDR, KIT, MAPK1, NPC1, OPRD1, TSHR |
BP | GO:0050896; response to stimulus | GO:0009636; response to toxic substance | 5.854E-06 | 4.767E-03 | CYP1A1, CYP1B1, KDR, MAPK1, OPRD1, POLB |
BP | GO:0065007; biological regulation | GO:0035625; epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 8.126E-06 | 5.204E-03 | ADRA2A, ADRA2C |
BP | GO:0009987; cellular process | GO:0032811; negative regulation of epinephrine secretion | 8.126E-06 | 5.204E-03 | ADRA2A, ADRA2C |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 8.126E-06 | 5.204E-03 | CYP1A1, CYP1A2 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 5.410E-07 | 6.222E-05 | CYP1A2; CYP1A1; CYP1B1; CYP19A1 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 5.737E-03 | 3.956E-02 | CYP1A2 |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.277E-05 | 5.168E-04 | CYP1A2; CYP1A1; CYP1B1 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 2.518E-03 | 2.196E-02 | CYP1A2; CYP1A1 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 7.840E-05 | 1.503E-03 | CYP1A2; CYP1A1; CYP1B1 |
hsa04014 | Ras signaling pathway_Homo sapiens_hsa04014 | 2.161E-03 | 2.129E-02 | KIT; KDR; MAPK1 |
hsa04015 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.754E-03 | 2.129E-02 | KIT; KDR; MAPK1 |
hsa04022 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 3.668E-05 | 8.437E-04 | OPRD1; MAPK1; ADRA2C; ADRA2A |
hsa04071 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 3.417E-04 | 4.913E-03 | OPRD1; ABCC1; MAPK1 |
hsa04080 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.348E-05 | 5.168E-04 | OPRD1; NMUR2; ADRA2C; ADRA2A; TSHR |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
C00-D49: Neoplasms | Metastatic breast cancer | C50 | KDR |
C00-D49: Neoplasms | Metastatic castration-resistant prostate cancer | C61 | KDR |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | KDR |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | KDR |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1 |
C00-D49: Neoplasms | Gastric cancer | C16 | KDR; KDR |
C00-D49: Neoplasms | Peritoneal cavity cancer | NA | KDR |